AAAAAA

   
Results: 1-7 |
Results: 7
A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: Differences in study outcomes
Authors: El-Sadr, WM Perlman, DC Denning, E Matts, JP Cohn, DL
Citation: Wm. El-sadr et al., A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: Differences in study outcomes, CLIN INF D, 32(4), 2001, pp. 623-632
The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial
Authors: Fisher, EJ Chaloner, K Cohn, DL Grant, LB Alston, B Brosgart, CL Schmetter, B El-Sadr, WM Sampson, J
Citation: Ej. Fisher et al., The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial, AIDS, 15(13), 2001, pp. 1695-1700
Discontinuation of prophylaxis against Mycobacterium avium complex diseasein HIV-infected patients who have a response to antiretroviral therapy.
Authors: El-Sadr, WM Burman, WJ Grant, LB Matts, JP Hafner, R Crane, L Zeh, D Gallagher, B Mannheimer, SB Martinez, A Gordin, F
Citation: Wm. El-sadr et al., Discontinuation of prophylaxis against Mycobacterium avium complex diseasein HIV-infected patients who have a response to antiretroviral therapy., N ENG J MED, 342(15), 2000, pp. 1085-1092
Photo quiz - Aberrant fat deposition (benign lipomatosis) in association with highly active antiretroviral therapy
Authors: Azmeh, W Rhagavan, SS El-Sadr, WM
Citation: W. Azmeh et al., Photo quiz - Aberrant fat deposition (benign lipomatosis) in association with highly active antiretroviral therapy, CLIN INF D, 28(2), 1999, pp. 239
Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens
Authors: Telzak, EE Chirgwin, KD Nelson, ET Matts, JP Sepkowitz, KA Benson, CA Perlman, DC El-Sadr, WM
Citation: Ee. Telzak et al., Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens, INT J TUBE, 3(4), 1999, pp. 337-343
Use of antiretroviral therapy by intravenous drug users with HIV
Authors: Mannheimer, SB Curtis, JL El-Sadr, WM
Citation: Sb. Mannheimer et al., Use of antiretroviral therapy by intravenous drug users with HIV, J AM MED A, 281(8), 1999, pp. 699-699
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both
Authors: El-Sadr, WM Murphy, RL Yurik, RM Luskin-Hawk, R Cheung, TW Balfour, HH Eng, R Hooton, TM Kerkering, TM Schutz, M van der Horst, C Hafner, R
Citation: Wm. El-sadr et al., Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both, N ENG J MED, 339(26), 1998, pp. 1889-1895
Risultati: 1-7 |